Radiopharmaceutical therapy (RPT) combined with external beam radiotherapy (EBRT) is emerging as a powerful approach in prostate cancer treatment. Historically rooted in early 89Sr trials, this ...

Figure][1] Michael Teitell, MD, PhD Dr. Michael Teitell is the director of the UCLA Health Jonsson Comprehensive Cancer ...

Radiopharmaceutical therapy (RPT) offers molecular-targeted treatment strategies and presents an ideal model for advancing ...

There are no established treatment options for patients with meningioma recurring after surgery and radiotherapy.

Journal of Nuclear Medicine December 2025, jnumed.125.270792; DOI: https://doi.org/10.2967/jnumed.125.270792 ...

Journal of Nuclear Medicine December 2025, jnumed.125.271097; DOI: https://doi.org/10.2967/jnumed.125.271097 ...

Journal of Nuclear Medicine December 2025, jnumed.125.271365; DOI: https://doi.org/10.2967/jnumed.125.271365 ...

The subjects of this study were those who underwent conventional wbPET imaging for clinical examination, for free medical treatment, or as part of the Japan Agency for Medical Research and Development ...

TO THE EDITOR: In the article written by Veit-Haibach et al. (1), the authors highlight the growing interest in the use of radiopharmaceuticals for both diagnosis and treatment, with a significant ...

Irène Buvat, PhD, Centre National de la Recherche Scientifique director of research and head of the Inserm Laboratory of Translational Imaging in Oncology at the Institut Curie, Orsay (France), and ...

Optical techniques, such as bioluminescence and fluorescence, are emerging as powerful new modalities for molecular imaging in disease and therapy. Combining innovative molecular biology and chemistry ...

Biochemical recurrence (BCR) after radical prostatectomy occurs in up to 40% of prostate cancer patients (1). Salvage radiotherapy (sRT) is recommended as the main curative option for patients with ...